-
公开(公告)号：US20140275154A1
公开(公告)日：2014-09-18
申请号：US14204292
申请日：2014-03-11
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Kyle J. Eastman , Kyle E. Parcella , John F. Kadow
IPC: C07D491/048
CPC classification number: C07D491/048 , C07D491/04
Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Abstract translation: 本公开提供式I化合物，包括其盐，以及使用该化合物的组合物和方法。 该化合物具有抗丙型肝炎病毒（HCV）的活性，可用于治疗HCV感染者。
-
公开(公告)号：US20170121340A1
公开(公告)日：2017-05-04
申请号：US15317541
申请日：2015-06-10
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao WANG , Zhongxing Zhang , Kyle E. Parcella , Kyle J. Eastman , John F. Kadow
IPC: C07D491/048 , C07D307/84
CPC classification number: C07D491/048 , C07D307/84 , C07D405/12 , C07D491/04
Abstract: Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:
-
公开(公告)号：US10214534B2
公开(公告)日：2019-02-26
申请号：US15317541
申请日：2015-06-10
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao Wang , Zhongxing Zhang , Kyle E. Parcella , Kyle J. Eastman , John F. Kadow
IPC: C07D491/048 , C07D405/12 , C07D491/04 , C07D307/84
Abstract: Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:
-
公开(公告)号：US08962651B2
公开(公告)日：2015-02-24
申请号：US14204292
申请日：2014-03-11
Applicant: Bristol-Myers Squibb Company
Inventor： Kyle J. Eastman , Kyle E. Parcella , John F. Kadow
IPC: A61K31/44 , C07D471/02 , C07D491/02 , C07D498/02 , C07D491/048 , C07D491/04
CPC classification number: C07D491/048 , C07D491/04
Abstract: The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Abstract translation: 本公开提供式I化合物，包括其盐，以及使用该化合物的组合物和方法。 该化合物具有抗丙型肝炎病毒（HCV）的活性，可用于治疗HCV感染者。
-
Patent Agency Ranking
5.发明授权Cyano containing azabenzofuran compounds for the treatment of hepatitis C 有权含有氮杂苯并呋喃化合物的Cyano用于治疗丙型肝炎公开(公告)号：US09249152B2
公开(公告)日：2016-02-02
申请号：US14663497
申请日：2015-03-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao Wang , Kyle J. Eastman , Zhongxing Zhang , Kyle E. Parcella , Zhiwei Yin , John F. Kadow
IPC: C07D491/048 , C07D491/04
CPC classification number: C07D491/048 , C07D491/04
Abstract: Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:
Abstract translation: 阐述了式I化合物，包括它们的盐，以及使用该化合物的组合物和方法。 该化合物具有抗丙型肝炎病毒（HCV）的活性，可用于治疗HCV感染者：
-
6.发明申请CYANO CONTAINING AZABENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C 有权含有氨苄青霉素化合物的CYANO用于治疗丙型肝炎公开(公告)号：US20150266886A1
公开(公告)日：2015-09-24
申请号：US14663497
申请日：2015-03-20
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao Wang , Kyle J. Eastman , Zhongxing Zhang , Kyle E. Parcella , Zhiwei Yin , John F. Kadow
IPC: C07D491/048
CPC classification number: C07D491/048 , C07D491/04
Abstract: Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:
Abstract translation: 阐述了式I化合物，包括它们的盐，以及使用该化合物的组合物和方法。 该化合物具有抗丙型肝炎病毒（HCV）的活性，可用于治疗HCV感染者：
-
公开(公告)号：US09957278B2
公开(公告)日：2018-05-01
申请号：US15500110
申请日：2015-08-04
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao Wang , Kyle J. Eastman , Zhongxing Zhang , Kyle E. Parcella , John F. Kadow
IPC: C07D491/048 , A61K31/4355 , C07B59/00
CPC classification number: C07D491/048 , C07B59/002 , C07B2200/05
Abstract: Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
-
公开(公告)号：US20170247385A1
公开(公告)日：2017-08-31
申请号：US15500110
申请日：2015-08-04
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Tao Wang , Kyle J. Eastman , Zhongxing Zhang , Kyle E. Parcella , John F. Kadow
IPC: C07D491/048 , C07B59/00
CPC classification number: C07D491/048 , C07B59/002 , C07B2200/05
Abstract: Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
-
公开(公告)号：US09738653B2
公开(公告)日：2017-08-22
申请号：US14773123
申请日：2014-03-12
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Kap-Sun Yeung , Kyle J. Eastman , Kyle E. Parcella
IPC: C07D491/048 , C07D491/04 , C07D307/84
CPC classification number: C07D491/048 , C07D307/84 , C07D491/04
Abstract: The disclosure provides compounds of formula I or II, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.015 seconds)
